Lynda Charters
Ultra-widefield angiography: New window for retinovascular features
Quantitative assessment of retinovascular features on ultra-widefield angiography images showed significant improvements in leakage and ischemia following treatment with aflibercept in patients with diabetic macular edema and retinal vein occlusion.
Contrast sensitivity device exposes vision limitations of reattachment patients
Computerized testing of contrast sensitivity function using the Sentio Platform (Adaptive Sensory Technology) may better quantify the visual limitations of patients than traditional letter acuity after retinal detachment repair.
Vitrectomy with brachytherapy shows no increase in metastatic risk
The metastatic prognosis does not increase when vitrectomy is performed at the time of brachytherapy.
OCTA: Future Is bright, fast, and wide in ROP
Advances in optical coherence tomography (OCT) and OCT angiography (OCTA) may enable more objective and accurate diagnosis of ROP in the future.
Subretinal therapy offers promise of lighter treatment burden for AMD
RGX-314 gene therapy offers patients the potential for a lower treatment burden with one subretinal injection of a gene therapy delivering an anti-vascular endothelial growth factor protein.
Phase IV study shows improved DME outcomes with fluocinolone acetonide implant
The fluocinolone acetonide 0.2 mcg/day implant (Iluvien, Alimera Sciences) offers an additional option for treating diabetic macular edema that reduces the need for subsequent therapy with anti-vascular endothelial growth factor or steroid treatment.
Povidone iodine reapplication: Protocol for preventing endophthalmitis
Take-Home Message: A pearl for preventing endophthalmitis following intravitreal injections: avoid eyelid contact with the injection site after the last application of povidone iodine.
Outcomes differ from trials with ‘real-world’ anti-VEGF therapy for DME
The visual outcomes after anti-VEGF therapy administered to treat diabetic macular edema in the “real world” do not achieve those reported in randomized clinical trials. Eyes with better baseline visual acuity are disproportionately affected.
How to manage patient’s IOL expectations pre-operatively
Patient selection is the key factor in obtaining the best visual outcomes after cataract surgery and intraocular lens implantation.

Poll

View Results